Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06256328
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-01-23
Brief Title:
A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer Including Esophagogastric Junction Cancer
Sponsor:
Ono Pharmaceutical Co Ltd
Organization:
Ono Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-23
First Submit QC Date:
February 4 2024
Study First Post Date:
2024-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-25
Last Update Post Date:
2024-05-08
Last Update Post Date Type:
ACTUAL